Prevention of herpes simplex virus type 2 transmission with antiviral therapy

Herpes

Volumn 11, Issue SUPPL. 3, 2004, Pages

  Corey, Lawrence ^a,c   Ashley, Rhoda ^b   McCloskey, J ^c   Denham, I ^c   Patten, J ^c   Pell, C ^c   Waddell, R ^c   Sodre, C T ^c   Bouchard, C ^c   Diaz Mitoma, F J ^c   Lassonde, M G ^c   Romanowski, B ^c   Sacks, S L ^c   Trottler, S ^c   Gubelin, W ^c   Guglielmetti, A ^c   Diaz, J ^c   Rubiano, N ^c   Roed Petersen, J ^c   Thestrup Pedersen, K ^c   Wulff, H C ^c   Kivimagi, K ^c   Poder, A ^c   Paavonen, J ^c   Saari, S ^c   Simpanen, A L ^c   Morel, P ^c   Ortonne, J P ^c   Cardamakis, E ^c   Mourelou, O ^c   Bornstein, J ^c   Dolitzky, M ^c   Dainys, B ^c   Laiskonis, A ^c   Soto, R G ^c   Pulido Olivares, V H ^c   Cairo, I ^c   Arama, V ^c   Balasoiu, V ^c   Capalna, M ^c   Giurcaneanu, C ^c   Popescu, S ^c   Tarlea, V ^c   Koubanova, A ^c   Martchenko, L ^c   Semenova, T ^c   Stratchounsky, L ^c   Ballesteros, J ^c   Varela, J A ^c   Strand, A ^c   Atakan, N ^c   Ozarmagan, G ^c   Adkins, G M ^c   Baker, D A ^c   Beutner, K R ^c   Beyerlein, R A ^c   Brady, R ^c   Cabezas Mijuste, M ^c   Clark, S ^c   Conant, M ^c   Drehobl, M A ^c   Douglas, J ^c   Faro, S ^c   Fife, K H ^c   Funk, S ^c   Gartman, D ^c   Garza, G ^c   Hart, D C ^c   Holmes, J A ^c   Koltun, W D ^c   Kraus, S J ^c   Kurtz, T ^c   Landwermeyer, M A ^c   Leone, P A ^c   Levin, M J ^c   Marbury, T C ^c   Marlowe, S I ^c   Marques, A ^c   Mertz, G ^c   Nett, R ^c   Pogue, B ^c   Poretz, D M ^c   Rosen, J ^c   Rowe, D H ^c   Salazar, G ^c   Schacker, T W ^c   Seraly, M ^c   Spencer, R P ^c   Stern, J ^c   Stone, S ^c   Thomas, E ^c   Tyring, S K ^c   Wald, A ^c   Warren, T ^c   Whiting, D A ^c   Wiener, M L ^c   Wiesenfeld, H ^c   Bowman, C ^c   more..

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c NONE

Author keywords

Antiviral therapy; Behavioural strategies; Genital ulcer disease; Herpes simplex virus; Heterosexual; HSV shedding; STI; Transmission; Valaciclovir

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; FAMCICLOVIR; PLACEBO; VALACICLOVIR;

CLINICAL TRIAL; CONDOM; CONFERENCE PAPER; DISTRESS SYNDROME; DRUG EFFICACY; GENITAL HERPES; GENITAL ULCER; HERPES SIMPLEX VIRUS 2; HETEROSEXUALITY; HUMAN; IMMUNOCOMPETENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT INFECTION; SAFE SEX; SEXUALLY TRANSMITTED DISEASE; VIRUS CULTURE; VIRUS SHEDDING; VIRUS TRANSMISSION;

HERPES; HUMAN HERPESVIRUS 2;

EID: 4344592187     PISSN: 09697667     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. Smith JS, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis 2002;186 (Suppl 1):S3-S28.
2. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis 2002;185: 45-52.
3. Mindel A. Psychological and psychosexual implications of herpes simplex virus infections. Scand J Infect Dis Suppl 1996:27-32.
4. Gilbert LK, Lloyd Schulz S, Ebel C. Education and counselling for genital herpes: perspectives from patients. Herpes 2002;9:78-82.
5. Inhorn M. Genital herpes: an ethnographic inquiry into being discreditable in American Society. Med Anthropol Q 1986;17:59-63.
6. Limandri B. Disclosure of stigmatizing conditions: the discloser's perspective. Arch Psychiatr Nurs 1989;3:69-78.
7. Patrick D, Stanberry L, Hurst C, Rosenthal SL. The IHMF/Novartis/IHA Genital Herpes Treatment Study (INSIGHTS): Physician and Patient Perceptions on Management (Abstract). 10th Annual Meeting of the IHMF, Paris, France, 28 February-2 March 2003. Herpes 2003;10:22.
8. Patel R. Educational interventions and the prevention of herpes simplex virus transmission. Herpes 2004;11:155A-160A.
9. Douglas JM, Critchlow C, Benedetti J, Mertz GJ, Connor JD, Hintz MA et al. A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection. N Engl J Med 1984;310:1551-1556.
10. Wald A, Corey L, Cone R, Hobson A, Davis G, Zeh J. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. J Clin Invest 1997;99: 1092-1097.
11. Wald A, Warrant T, Hu H. Suppression of subclinical shedding of herpes simplex virus type 2 in the genital tract with valaciclovir (Abstract H-82). 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, California, USA, 1998.
12. Corey L, Wald A, Patel R, Sacks SL, Tyring SK, Warren T et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004;350:11-20.
13. Patel R, Bodsworth NJ, Woolley P, Peters B, Vejlsgaard G, Saari S et al. Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group. Genitourin Med 1997;73:105-109.
14. Reitano M, Tyring S, Lang W, Thoming C, Worm AM, Borelli S et al. Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study. International Valaciclovir HSV Study Group. J Infect Dis 1998;178:603-610.
15. Diaz-Mitoma F, Sibbald RG, Shafran SD, Boon R, Saltzman RL. Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial. Collaborative Famciclovir Genital Herpes Research Group. JAMA 1998;280:887-892.
16. Wald A, Zeh J, Barnum G, Davis LG, Corey L. Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir. Ann Intern Med 1996; 124:8-15.
17. Koelle DM, Wald A. Herpes simplex virus: the importance of asymptomatic shedding. J Antimicrob Chemother 2000;45(Suppl T3):1-8.
18. Wald A, Zeh J, Selke S, Warren T, Ashley R, Corey L. Genital shedding of herpes simplex virus among men. J Infect Dis 2002;186 (Suppl 1):S34-S39.
19. Sacks SL. Improving the management of genital herpes. Hosp Pract (Off Ed) 1999;34:41-49; quiz 139.
20. Corey L, Tyring S, Beutner K, Warren T, Sacks S, Patel R et al. Once daily valaciclovir reduces transmission of genital herpes (Abstract LB-3). 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, California, 2002.
21. Blower SM, Wald A, Gershengorn HB, Wang F, Corey L. Targeting virological core groups: a new paradigm for controlling HSV-2 epidemics. J Infect Dis 2004 (in press).
22. Wald A, Langenberg AG, Link K, Izu AE, Ashley R, Warren T et al. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA 2001;285:3100-3106.
23. Mertz GJ, Coombs RW, Ashley R, Jourden J, Remington M, Winter C et al. Transmission of genital herpes in couples with one symptomatic and one asymptomatic partner: a prospective study. J Infect Dis 1988;157:1169-1177.
24. Corey L, Langenberg AG, Ashley R, Sekulovich RE, Izu AE, Douglas JM, Jr et al. Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group. JAMA 1999;282: 331-340.
25. Stanberry LR, Spruance SL, Cunningham AL, Bernstein DI, Mindel A, Sacks S et al. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med 2002; 347:1652-1661.
26. Conant MA, Schacker TW, Murphy RL, Gold J, Crutchfield LT, Crooks RJ. Valaciclovir versus aciclovir for herpes simplex virus infection in HIV-infected individuals: two randomized trials. Int J STD AIDS 2002;13: 12-21.